financetom
Business
financetom
/
Business
/
Legence Prices IPO, Targets $688 Million Net Proceeds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Legence Prices IPO, Targets $688 Million Net Proceeds
Sep 12, 2025 1:11 AM

03:43 AM EDT, 09/12/2025 (MT Newswires) -- Legence (LGN) said late Thursday it has priced an initial public offering of 26 million shares at $28 each for expected net proceeds of around $688 million.

The building services provider granted underwriters a 30-day option to purchase up to 3.9 million additional shares.

The shares are expected to begin Nasdaq trading Friday under the ticker symbol "LGN" while the offering is expected to close on Monday, the company said.

Legence plans to use the net proceeds to pay down its term loan credit facility and for general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adventus Mining Says Key Authorization for El Domo-Curipamba Project in Ecuador Facing Legal Challenge
Adventus Mining Says Key Authorization for El Domo-Curipamba Project in Ecuador Facing Legal Challenge
Jun 17, 2024
08:06 AM EDT, 06/17/2024 (MT Newswires) -- Adventus Mining ( ADVZF ) and Salazar Resources (SRL.V) on Monday said a previously obtained key authorization for the El Domo-Curipamba project is being challenged in the Ecuadorian courts. Adventus obtained the environmental license for the mine's construction and operation phase on January 19 from the Ministry of Environment, Water, and Ecological Transition...
Top Premarket Decliners
Top Premarket Decliners
Jun 17, 2024
08:02 AM EDT, 06/17/2024 (MT Newswires) -- Ovid Therapeutics ( OVID ) shares slumped 64% Monday premarket after the company said that phase 3 studies conducted by Takeda evaluating Soticlestat in certain types of epilepsy missed their primary endpoints. Kaival Brands Innovations Group ( KAVL ) shares fell 35%, paring Friday's rally. La Rosa Holdings ( LRHC ) shares retreated...
Marinus Pharmaceuticals Epilepsy Treatment Falls Short in Phase 3 Study
Marinus Pharmaceuticals Epilepsy Treatment Falls Short in Phase 3 Study
Jun 17, 2024
08:03 AM EDT, 06/17/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) said on Monday that its experimental drug, intravenous ganaxolone, aimed at treating refractory status epilepticus - a condition where seizures persist despite standard treatments - did not achieve one of its primary goals in a Phase 3 study, sending shares down by 8.5% in premarket trading. Marinus said...
Naver's Webtoon Entertainment targets up to $2.67 bln valuation in US IPO
Naver's Webtoon Entertainment targets up to $2.67 bln valuation in US IPO
Jun 17, 2024
June 17 (Reuters) - Online comics platform Webtoon Entertainment said on Monday it is targeting a valuation of up to $2.67 billion in its initial public offering in the United States. The company, majority-owned by South Korean tech giant Naver , is aiming to raise as much as $315 million by offering 15 million shares at a price range of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved